Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Union leaders will meet executives at AstraZeneca today to try to convince Britain’s second-biggest drugmaker to reverse plans to close its R&D site in Cheshire and move almost 2,000 jobs. AstraZeneca wants to move its R&D hub from Alderley Park in Cheshire to Cambridge by 2016. The pharma giant is suffering as a string of drugs run out of patent, with few new hopes in the pipeline to replace those lost revenues. Its two top-selling drugs, Nexium ulcer pills and the Crestor cholesterol-buster, see their US patents expire in 2014 and 2016.
Help employers find you! Check out all the jobs and post your resume.
